Form 13-F position report

MINERVA NEUROSCIENCES INC COM

Reported by ROYAL BANK OF CANADA

NERV CUSIP 603380205 Manager CIK 0001000275

Reported 1,829 shares, up 1,280 (233.2%) from the prior quarter.

Reported value 500.0%; share count 233.2% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2024
Shares 1,829 Quarter-end amount reported
Reported value $6,000 Fair value at quarter end
Consecutive quarters held 8 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 0
2022-09-30 11000
2022-12-31 0
2023-03-31 0
2023-06-30 2000
2023-09-30 9000
2023-12-31 3000
2024-03-31 1000
2024-06-30 6000
2024-09-30 0
2024-12-31 3000
2025-03-31 0
2025-06-30 0
2025-09-30 5000
2025-12-31 9000
2026-03-31 1000
2026-06-30 7000

Quarterly position history

How this manager's reported quarter-end position changed over time.

17 quarters
Quarterly reported position history for MINERVA NEUROSCIENCES INC COM held by ROYAL BANK OF CANADA.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 1,236 +1,144 (1243.5%) < 0.01% $7,000 2026-08-14
Q1 2026 Reduced 92 -2,148 (-95.9%) < 0.01% $1,000 2026-05-15
Q4 2025 Reduced 2,240 -190 (-7.8%) < 0.01% $9,000 2026-02-17
Q3 2025 Added 2,430 +2,378 (4573.1%) < 0.01% $5,000 2025-11-14
Q2 2025 Reduced 52 -100 (-65.8%) 0 $0 2025-08-14
Q1 2025 Reduced 152 -1,393 (-90.2%) 0 $0 2025-05-15
Q4 2024 New 1,545 +1,545 (0.0%) < 0.01% $3,000 2025-02-14
Q3 2024 Reduced 0 -1,829 (-100.0%) 0 $0 2024-11-14
Q2 2024 Added 1,829 +1,280 (233.2%) < 0.01% $6,000 2024-08-14
Q1 2024 Added 549 +55 (11.1%) < 0.01% $1,000 2024-05-15
Q4 2023 Reduced 494 -831 (-62.7%) < 0.01% $3,000 2024-02-14
Q3 2023 Added 1,325 +1,107 (507.8%) < 0.01% $9,000 2023-11-14
Q2 2023 Added 218 +42 (23.9%) < 0.01% $2,000 2023-08-14
Q1 2023 New 176 +176 (0.0%) 0 $0 2023-05-15
Q4 2022 Reduced 0 -1,181 (-100.0%) 0 $0 2023-02-14
Q3 2022 New 1,181 +1,181 (0.0%) < 0.01% $11,000 2022-11-14
Q3 2021 Reduced 0 -9,011 (-100.0%) 0 $0 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

21 managers reported MINERVA NEUROSCIENCES INC COM for Q2 2024.

Managers reporting MINERVA NEUROSCIENCES INC COM in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FEDERATED HERMES INC Unchanged 1,351,275 0 0.01% $4,310,567 9 qtrs
VANGUARD GROUP INC Unchanged 252,060 0 < 0.01% $804,072 9 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 167,700 -10,065 < 0.01% $534,963 9 qtrs
UBS OCONNOR LLC Added 99,856 +212 < 0.01% $318,541 4 qtrs
BlackRock Inc Unchanged 72,669 0 < 0.01% $231,814 9 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 55,111 +2,519 < 0.01% $175,850 9 qtrs
NORTHERN TRUST CORPORATION Reduced 23,049 -37 < 0.01% $73,526 3 qtrs
ACADIAN ASSET MANAGEMENT LLC Unchanged 17,423 0 < 0.01% $55,000 9 qtrs
STATE STREET CORPORATION Unchanged 16,519 0 < 0.01% $52,696 9 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 11,938 -4,743 < 0.01% $38,082 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 14, 2024
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
1,829
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.